# US Neurovascular Devices Market > US Neurovascular Devices Market Research Report: Size, Share, Trend Analysis By Device Type (Interventional Neurology Devices, Neurovascular Stents, Embolic Agents, Catheters, Flow Diverters), By Applications (Aneurysm Treatment, Arteriovenous Malformation Treatment, Intracranial Atherosclerotic Disease, Ischemic Stroke, Hemorrhagic Stroke) and By End Use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.09% - **2024:** $ 1,467.31 Million - **2025:** $ 1,556.67 Million - **2035:** $ 2,810.44 Million - **Key Players:** Medtronic (US), Stryker (US), Boston Scientific (US), Johnson & Johnson (US), Terumo (JP), Penumbra (US), MicroVention (US), Asahi Intecc (JP) **Report ID:** MRFR/MED/13124-HCR · **Pages:** 100 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-neurovascular-devices-market-14651 --- ## Market Summary ## **US Neurovascular Devices Market Overview** **As per MRFR analysis, the US Neurovascular Devices Market Size was estimated at 1.04 (USD Billion) in 2023. The US Neurovascular Devices Market Industry is expected to grow from 1.1 (USD Billion) in 2024 to 2.2 (USD Billion) by 2035.** The US Neurovascular Devices Market CAGR (growth rate) is expected to be around 6.504% during the forecast period (2025 - 2035). ## **Key US Neurovascular Devices Market Trends Highlighted** The US Neurovascular Devices Market is witnessing several important trends that are shaping its future. One major driver is the increasing prevalence of neurovascular diseases such as stroke and aneurysms, leading to a greater demand for advanced medical devices. The aging population in the US also plays a significant role, as older individuals are more susceptible to neurovascular conditions. Additionally, advancements in technology are driving innovation, with companies developing minimally invasive devices that enhance patient outcomes. These new technologies are often supported by favorable regulatory policies that streamline the approval processes for new [**neurovascular devices**](../../../reports/neurovascular-devices-market-5544). There are numerous opportunities to be explored within the US market. For instance, there is potential for growth in specialized devices aimed at treating specific conditions within neurovascular issues. The rise of telemedicine and remote monitoring solutions also offers avenues to improve patient engagement and follow-up care. Furthermore, partnerships between device manufacturers and healthcare providers can facilitate the adoption of new technologies, ultimately improving treatment efficacy. Recent trends indicate an increasing focus on safety and efficacy in the development of neurovascular devices. This is evident through rigorous clinical trials and post-market surveillance that prioritize patient safety. There is also a significant shift toward using artificial intelligence in the analysis of imaging and treatment planning, further enhancing the accuracy and effectiveness of interventions. As patient awareness regarding neurovascular issues rises, there is an increasing demand for educational resources and support, prompting companies to enhance their outreach efforts. Collectively, these trends reflect a dynamic and evolving landscape within the US Neurovascular Devices Market, characterized by innovation, consumer demand, and a focus on improved healthcare outcomes. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Neurovascular Devices Market Drivers** ### **Increasing Prevalence of Neurological Disorders** In recent years, the United States has been witnessing a significant rise in neurological disorders, particularly stroke and aneurysms, which is expected to drive the demand for neurovascular devices. A report from the Centers for Disease Control and Prevention (CDC) indicates that nearly 795,000 people in the United States experience a stroke each year, which translates to approximately one in every 6 deaths in the country, making stroke a leading cause of death in the US. Additionally, with an aging population as the Baby Boomer generation continues to age, projections suggest that the incidence of conditions like ischemic stroke will increase by nearly 20% over the next decade. Major organizations, such as the American Heart Association, are actively investing in educational and preventive programs to reduce neurological disorders, thereby increasing awareness and demand for neurovascular therapies in the US Neurovascular Devices Market Industry. ### **Technological Advancements in Neurovascular Devices** The growth of the US Neurovascular Devices Market Industry is significantly fueled by continuous innovations in technology. Advanced devices such as aspiration catheters, stent retrievers, and flow diverters have improved the effectiveness of neurovascular procedures. According to findings shared by the Food and Drug Administration (FDA), neurovascular devices are now seeing enhanced performance with reduced complications due to these technological advancements. Furthermore, numerous companies, including Medtronic and Stryker, are heavily investing in Research and Development (R&D) to enhance device efficacy, including devices that provide real-time imaging and minimally invasive techniques, which cater to a growing preference for outpatient procedures. These advancements are projected to play a crucial role in driving market growth in the coming years. ### **Government Initiatives to Enhance Healthcare Accessibility** In an effort to improve healthcare access and treatment outcomes, the US government has implemented various policies and initiatives in recent years. The Affordable Care Act has played a significant role in expanding healthcare coverage, thus benefitting more patients requiring neurovascular treatments. According to the Department of Health and Human Services, the expansion of Medicaid in various states has enabled lower-income populations to access critical neurovascular care, leading to higher demand for neurovascular devices. Additionally, government funding for stroke treatment initiatives and guidelines for addressing neurological disorders have encouraged advancements in the US Neurovascular Devices Market Industry. Such initiatives are crucial for improving outcomes and reducing the overall burden of disease in the US. ## **US Neurovascular Devices Market Segment Insights** ### **Neurovascular Devices Market Device Type Insights** The Device Type segment of the US Neurovascular Devices Market encompasses several critical categories, each playing a decisive role in addressing neurovascular conditions. **Interventional Neurology Devices** represent a crucial component, focusing on advanced minimally invasive techniques that facilitate effective treatment of conditions like aneurysms and arteriovenous malformations. Their significance continues to rise with an increased preference for patient-centric approaches that reduce recovery times and improve outcomes. **Neurovascular Stents** are vital as they provide support for narrowed or weakened blood vessels in the brain, preventing complications such as strokes. These devices are gaining traction due to ongoing technological advancements that enhance their efficacy and safety. Embolic Agents serve as another major category, utilized primarily in occluding blood vessels to mitigate risks associated with hemorrhagic events. Their contribution to treatment strategies has been pivotal, given the rising incidence of related health complications. Catheters are fundamental tools in the neurovascular field, allowing for precise navigation within the vascular system to deliver therapies or contrast agents. The expansion of catheter technologies enhances procedural success rates and minimizes potential risks during neurovascular interventions. Lastly, Flow Diverters are becoming increasingly significant as they enable the treatment of large and complex vascular lesions through a flow-modifying mechanism. Their role in promoting stable hemodynamics makes them an essential asset in neurovascular treatments. Overall, the Device Type segment reflects a diversifying landscape with continued innovation and adoption that addresses the evolving needs of patients in the US. Ongoing trends, such as the integration of robotics and imaging advancements, promise to shape the future direction of these devices, and the overall growth of the US Neurovascular Devices Market underlines the importance of this segment. The interplay of technological enhancement, regulatory approvals, and the growing aging population further highlights the importance of each category in the market, ensuring that these devices will continue to play a crucial role in the management of neurovascular diseases. ### Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Neurovascular Devices Market Application Insights** The US Neurovascular Devices Market is characterized by its diverse applications that address a range of critical conditions related to the vascular system of the brain. Notably, **Aneurysm Treatment** represents a significant portion of the market, as the prevalence of aneurysms necessitates advanced therapies and devices. Similarly, **Arteriovenous Malformation Treatment** is crucial because these malformations can lead to serious health complications and require innovative surgical approaches and devices for management. The Intracranial Atherosclerotic Disease segment emphasizes the rising incidence of cerebrovascular diseases, driving demand for effective treatment solutions. Moreover, the increasing rates of Ischemic Stroke and Hemorrhagic Stroke highlight the urgent need for neurovascular devices that can enhance patient outcomes and reduce the risk of recurrence. These segments collectively demonstrate the importance of effective neurovascular treatments, with each application serving specific patient needs while contributing to the overall growth of the US Neurovascular Devices Market. With advancements in technology, research and development are poised to play an essential role in addressing the challenges posed by these conditions, ultimately leading to improved therapeutic options for patients across the United States. ### **Neurovascular Devices Market End Use Insights** The End Use segment of the US Neurovascular Devices Market is critical, as it includes key healthcare facilities like Hospitals, Ambulatory Surgical Centers, and Specialty Clinics, which are vital for the treatment and management of neurovascular conditions. Hospitals typically serve as the primary sites for advanced neurovascular interventions, given their capacity for comprehensive care and access to sophisticated technology. In contrast, Ambulatory Surgical Centers are gaining traction due to their cost-effectiveness and efficiency in performing outpatient procedures, thus catering to patients who require less intensive treatment. Specialty Clinics focus specifically on neurovascular care, offering tailored services and expertise that enhance patient outcomes. The combination of these end-use facilities reflects an evolving landscape, where increased investment in healthcare infrastructure and technological advancements drive market growth. Challenges, such as regulatory hurdles and high costs of neurovascular devices, present opportunities for innovation and collaboration among stakeholders. With the rising prevalence of neurovascular disorders, the importance of these end-use settings continues to grow, highlighting their significant role in shaping the overall landscape of the US Neurovascular Devices Market. ## **US Neurovascular Devices Market Key Players and Competitive Insights** The US Neurovascular Devices Market has exhibited considerable dynamism, driven by a blend of technological advancements, an aging population, and an increasing prevalence of neurological disorders such as stroke and aneurysms. Competitive insights in this market highlight a range of companies leveraging innovation to enhance patient outcomes and procedural efficiency. Key players are focusing on the development of next-generation devices that not only improve the effectiveness of treatment but also minimize risks for patients. The strategic landscape consists of various companies actively pursuing partnerships, mergers, and acquisitions to strengthen their market position and expand their product portfolios. As a result, this competitive environment is contributing to rapid advances in neurovascular therapies and an overall enhancement in healthcare delivery for patients suffering from neurovascular conditions. ### **Neuravi** Neuravi, as a competitor in the US Neurovascular Devices Market, has established a solid presence by emphasizing innovative solutions specifically designed for neurovascular procedures. The company is recognized for its advanced thrombectomy systems, targeting the effective removal of blood clots from cerebral vessels. Neuravi's unique technology aims to reduce procedural times and enhance the overall safety profile of interventions. Their commitment to research and development enables them to stay ahead of market trends and regulatory changes, allowing the company to bring impactful, high-quality products to the market. The strength of Neuravi lies in its focus on clinician feedback to enhance product design, fostering relationships with healthcare professionals that bolster brand loyalty and encourage wider adoption of their devices. ### **B. Braun** B. Braun is a significant player in the US Neurovascular Devices Market, known for a diverse range of high-quality medical devices and solutions. The company offers a number of key products and services tailored for neurovascular treatments, including embolization coils and microcatheters designed for minimally invasive procedures. B. Braun maintains a strong market presence due to its established reputation and extensive distribution network, enabling access to a wide variety of healthcare facilities across the United States. The company has been actively involved in mergers and acquisitions aimed at expanding its product lineup and enhancing its technological capabilities. This strategic approach ensures a robust competitive edge while affirming B. Braun's commitment to innovation and excellence in patient care in the neurovascular field. Its ability to combine cutting-edge technology with reliable service solidifies B. Braun's position as a leader in the US market. ### **Key Companies in the US Neurovascular Devices Market Include** - Neuravi - B. Braun - Institute for Neuroinnovation - [**Medtronic**](https://www.medtronic.com/en-us/healthcare-professionals/products.html) - Boston Scientific - Abbott Laboratories - Nico Neurovascular - Cerenovus - Stryker - MicroVention - Terumo - Penumbra - Asahi Intecc - Johnson and Johnson ## **US Neurovascular Devices Market Industry Developments** The US Neurovascular Devices Market has seen significant developments recently, notably in the areas of product advancements and market dynamics. As of October 2023, companies such as Medtronic and Boston Scientific have been leading in the innovation of neurovascular technologies, introducing devices like the Embozene microspheres and advancements in stent retrievers that enhance the treatment of cerebrovascular diseases. Additionally, Neuravi has made strides in the development of neurothrombectomy devices, contributing to improved patient outcomes. The market is also witnessing robust growth, driven by an increasing prevalence of neurological disorders and advancements in healthcare technologies. Mergers and acquisitions have been pivotal, with **Cerenovus acquiring certain assets from Medtronic** in July 2023 to strengthen their portfolio. Furthermore, Johnson and Johnson announced in August 2023 a strategic partnership with **Abbott Laboratories focused on expanding the accessibility** of cutting-edge neurovascular devices. Over the past two to three years, significant investments have been directed towards Research and Development across these companies, thereby enhancing competitive strategies and expanding market reach within the US Neurovascular Devices industry. ## **US Neurovascular Devices Market Segmentation Insights** ### **Neurovascular Devices Market Device Type Outlook** - Interventional Neurology Devices - Neurovascular Stents - Embolic Agents - Catheters - Flow Diverters ### **Neurovascular Devices Market Application Outlook** - Aneurysm Treatment - Arteriovenous Malformation Treatment - Intracranial Atherosclerotic Disease - Ischemic Stroke - Hemorrhagic Stroke ### **Neurovascular Devices Market End Use Outlook** - Hospitals - Ambulatory Surgical Centers - Specialty Clinics ## Market Drivers ### Growing Awareness and Education There is a notable increase in awareness and education regarding neurological health among both healthcare professionals and the general public. Campaigns aimed at educating individuals about the signs and symptoms of neurological disorders are becoming more prevalent. This heightened awareness is likely to lead to earlier diagnosis and treatment, thereby increasing the demand for neurovascular devices. Furthermore, healthcare providers are receiving more training on the latest technologies and treatment protocols, which enhances their ability to utilize these devices effectively. As a result, the neurovascular devices market is expected to benefit from this trend, as more patients seek timely interventions and advanced treatment options. ### Investment in Research and Development Significant investment in research and development (R&D) is propelling the neurovascular devices market forward. Companies are increasingly allocating resources to innovate and enhance device efficacy, safety, and usability. The US government, alongside private entities, has been funding numerous initiatives aimed at advancing neurovascular technologies. For instance, the National Institutes of Health (NIH) has dedicated millions of dollars to research projects focused on stroke prevention and treatment. This influx of funding is likely to lead to the introduction of cutting-edge devices, which could capture a larger market share and improve clinical outcomes. As a result, the neurovascular devices market is poised for growth, driven by continuous innovation and technological advancements. ### Technological Integration in Healthcare The integration of advanced technologies such as artificial intelligence (AI) and machine learning into healthcare is influencing the neurovascular devices market. These technologies are being utilized to enhance diagnostic accuracy and treatment planning, leading to improved patient outcomes. For instance, AI algorithms can analyze imaging data to identify potential neurovascular issues more efficiently. This technological integration not only streamlines workflows but also increases the demand for sophisticated neurovascular devices that can work in tandem with these innovations. As healthcare systems in the US continue to adopt these technologies, the neurovascular devices market is likely to experience significant growth, driven by the need for devices that complement advanced diagnostic tools. ### Regulatory Support and Approval Processes Regulatory support and streamlined approval processes for neurovascular devices are contributing to market growth. The US Food and Drug Administration (FDA) has been working to expedite the review and approval of innovative medical devices, particularly those addressing critical health issues like stroke and aneurysms. This supportive regulatory environment encourages manufacturers to invest in the development of new devices, knowing that they may receive quicker market access. As a result, the neurovascular devices market is likely to see an influx of new products, enhancing competition and providing healthcare providers with a broader range of treatment options. This trend may ultimately lead to improved patient care and outcomes. ### Rising Incidence of Neurological Disorders The increasing prevalence of neurological disorders in the US is a primary driver for the neurovascular devices market. Conditions such as stroke, aneurysms, and arteriovenous malformations are becoming more common, necessitating advanced treatment options. According to recent data, stroke is the fifth leading cause of death in the US, with approximately 795,000 individuals affected annually. This growing patient population creates a substantial demand for innovative neurovascular devices, as healthcare providers seek effective solutions to manage these conditions. The neurovascular devices market is expected to expand as hospitals and clinics invest in advanced technologies to improve patient outcomes and reduce mortality rates associated with neurological disorders. ## Future Outlook The [Neurovascular Devices Market](https://www.marketresearchfuture.com/reports/neurovascular-devices-market-5544) is projected to grow at a 6.09% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of neurovascular diseases, and rising healthcare expenditure. **New opportunities:** - Development of AI-driven diagnostic tools for early detection of neurovascular conditions. Expansion of telehealth services for remote monitoring of patients with neurovascular devices. Partnerships with healthcare providers for integrated care solutions in neurovascular treatment. By 2035, The neurovascular devices market is expected to achieve significant growth, reflecting evolving healthcare needs. ## Segment Insights ### By Type: Interventional Neurology Devices (Largest) vs. Neurovascular Stents (Fastest-Growing) The US neurovascular devices market is characterized by a diverse range of segment values, with Interventional Neurology Devices capturing the largest share due to advanced technological developments and increased adoption rates. Neurovascular Stents follow closely, gaining prominence among healthcare providers for their effectiveness in treating vascular diseases, which has led to a significant portion of the market share being attributed to these devices. Growth trends within this segment are fueled by the rising incidences of neurovascular disorders and an increasing aging population, subsequently driving demand for minimally invasive procedures. Additionally, continuous innovations in product design and materials are enhancing the performance and safety of these devices, with Neurovascular Stents being recognized as the fastest-growing segment owing to their pivotal role in treating complex aortic pathologies. Interventional Neurology Devices: Dominant vs. Neurovascular Stents: Emerging Interventional Neurology Devices are the dominant force in the neurovascular devices market, encompassing a wide array of technologies such as thrombolysis and thrombectomy systems, which are instrumental in treating critical conditions like strokes. These devices are preferred for their ability to provide immediate intervention and high efficacy rates. In contrast, Neurovascular Stents are emerging as a key player within this landscape, renowned for their ability to assist in maintaining vessel patency and preventing stroke recurrence. This segment is rapidly gaining ground due to improvements in stent design, biocompatibility, and enhanced delivery systems, establishing itself as an essential part of neurovascular therapy with a robust growth trajectory. ### By Application: Aneurysm Treatment (Largest) vs. Ischemic Stroke (Fastest-Growing) The market share distribution within the application segment of the US neurovascular devices market highlights Aneurysm Treatment as the largest segment, commanding a significant portion of the market. Other segments such as Ischemic Stroke, Arteriovenous Malformation Treatment, Hemorrhagic Stroke, and Intracranial Atherosclerotic Disease also contribute compellingly to the overall market landscape, each catering to critical health challenges faced in the neurological domain. Ischemic Stroke is recognized as the fastest-growing segment, driven by an increasing prevalence of stroke cases and advances in treatment technologies. The growing awareness of stroke symptoms and the urgent need for timely intervention are propelling investments in this area. Additionally, robust healthcare initiatives and improved access to neurovascular care are anticipated to expand the market further, enhancing treatment outcomes for patients with various neurovascular conditions. Aneurysm Treatment (Dominant) vs. Ischemic Stroke (Emerging) Aneurysm Treatment continues to dominate the US neurovascular devices market, primarily due to its established protocols and the effectiveness of various devices employed in surgical repairs. This segment benefits from a well-defined patient population that requires ongoing monitoring and interventions. On the other hand, Ischemic Stroke is an emerging segment gaining traction due to rising incidences and the advent of innovative treatment modalities. The rapid evolution of neurointerventional techniques and devices for Ischemic Stroke is transforming patient outcomes, resulting in increased growth potential for this area. Both segments reflect distinct characteristics that cater to specific clinical needs while showcasing the dynamic nature of the market. ### By End Use: Hospitals (Largest) vs. Specialty Clinics (Fastest-Growing) The US neurovascular devices market is significantly dominated by the hospitals segment, which holds the largest share among all end-use categories. Hospitals provide critical care and advanced treatment options, drawing a significant number of patients requiring neurovascular interventions. In contrast, ambulatory surgical centers and specialty clinics are gaining traction, though they possess comparatively smaller shares in the market. This dynamic illustrates the preference for hospitals, where comprehensive care and experienced personnel are available to handle complex procedures. Growth trends in the end-use segment are influenced by the increasing incidence of neurovascular diseases and the rising demand for minimally invasive procedures. Specialty clinics, in particular, are emerging rapidly as they offer targeted treatments, shorter waiting times, and improved patient experience. Technological advancements and innovative treatment modalities are further propelling growth in ambulatory surgical centers, making them an attractive option for patients seeking efficient care. Hospitals (Dominant) vs. Specialty Clinics (Emerging) Hospitals remain the dominant force in the neurovascular devices segment, known for their extensive resources, specialized staff, and capacity to handle complex cases. They offer a wide range of neurovascular procedures, providing a crucial setting for acute care and recovery. On the other hand, specialty clinics are emerging as a significant player by focusing on specific neurovascular treatments, which allows them to cater to the growing demand for expert care while maintaining efficiency. These clinics benefit from advancements in technology and methodologies that enhance patient outcomes, driving their rapid growth in the market. As patient preferences shift towards specialized and efficient care options, the role of specialty clinics is poised to increase. ## Competitive Benchmarking The neurovascular devices market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of neurovascular diseases. Key players such as Medtronic (US), Stryker (US), and Boston Scientific (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market positions. Medtronic (US) emphasizes its commitment to developing cutting-edge solutions, particularly in thrombectomy devices, while Stryker (US) is known for its robust portfolio in neurovascular interventions, leveraging its extensive distribution network to penetrate deeper into the market. Boston Scientific (US) appears to be concentrating on expanding its product offerings through acquisitions and collaborations, thereby enhancing its competitive edge in this rapidly evolving sector.The business tactics employed by these companies include localizing manufacturing and optimizing supply chains to improve efficiency and reduce costs. The market structure is moderately fragmented, with several players vying for market share. However, the collective influence of major companies like Medtronic (US) and Stryker (US) suggests a trend towards consolidation, as these firms seek to leverage their resources and capabilities to dominate the market. In October Medtronic (US) announced the launch of its latest thrombectomy device, which integrates advanced imaging technology to enhance procedural accuracy. This strategic move is likely to solidify Medtronic's position as a leader in the neurovascular space, as it addresses the growing demand for minimally invasive solutions that improve patient outcomes. The introduction of this device not only showcases Medtronic's commitment to innovation but also reflects a broader trend towards the integration of technology in medical devices. In September Stryker (US) expanded its partnership with a leading telehealth provider to enhance remote monitoring capabilities for neurovascular patients. This collaboration is indicative of Stryker's strategic focus on digital transformation, aiming to improve patient engagement and streamline care pathways. By integrating telehealth solutions, Stryker is positioning itself to meet the evolving needs of healthcare providers and patients alike, potentially leading to improved treatment adherence and outcomes. In August Boston Scientific (US) completed the acquisition of a promising startup specializing in AI-driven neurovascular imaging solutions. This acquisition is expected to bolster Boston Scientific's technological capabilities, allowing it to offer more sophisticated diagnostic tools. The integration of AI into neurovascular devices may enhance the precision of interventions, thereby attracting a broader customer base and reinforcing Boston Scientific's competitive stance in the market. As of November current competitive trends in the neurovascular devices market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are increasingly shaping the landscape, as companies recognize the value of collaboration in driving innovation. Looking ahead, competitive differentiation is likely to evolve, with a greater emphasis on technological advancements and supply chain reliability rather than solely on price. This shift suggests that companies that prioritize innovation and adaptability will be better positioned to thrive in the future. ## Recent News & Developments The US Neurovascular Devices Market has seen significant developments recently, notably in the areas of product advancements and market dynamics. As of October 2023, companies such as Medtronic and Boston Scientific have been leading in the innovation of neurovascular technologies, introducing devices like the Embozene microspheres and advancements in stent retrievers that enhance the treatment of cerebrovascular diseases. Additionally, Neuravi has made strides in the development of neurothrombectomy devices, contributing to improved patient outcomes. The market is also witnessing robust growth, driven by an increasing prevalence of neurological disorders and advancements in healthcare technologies. Mergers and acquisitions have been pivotal, with **Cerenovus acquiring certain assets from Medtronic** in July 2023 to strengthen their portfolio. Furthermore, Johnson and Johnson announced in August 2023 a strategic partnership with **Abbott Laboratories focused on expanding the accessibility** of cutting-edge neurovascular devices. Over the past two to three years, significant investments have been directed towards Research and Development across these companies, thereby enhancing competitive strategies and expanding market reach within the US Neurovascular Devices industry. ## Report Scope | MARKET SIZE 2024 | 1467.31(USD Million) | | --- | --- | | MARKET SIZE 2025 | 1556.67(USD Million) | | MARKET SIZE 2035 | 2810.44(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.09% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Medtronic (US), Stryker (US), Boston Scientific (US), Johnson & Johnson (US), Terumo (JP), Penumbra (US), MicroVention (US), Asahi Intecc (JP) | | Segments Covered | Type, Application, End Use | | Key Market Opportunities | Advancements in minimally invasive techniques enhance growth potential in the neurovascular devices market. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the neurovascular devices market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What is the current valuation of the US neurovascular devices market?** A: The market valuation was $1467.31 Million in 2024. **Q: What is the projected market size for the US neurovascular devices market by 2035?** A: The projected valuation for 2035 is $2810.44 Million. **Q: What is the expected CAGR for the US neurovascular devices market during 2025 - 2035?** A: The expected CAGR during this period is 6.09%. **Q: Which companies are the key players in the US neurovascular devices market?** A: Key players include Medtronic, Stryker, Boston Scientific, Johnson & Johnson, Terumo, Penumbra, MicroVention, and Asahi Intecc. **Q: What are the main segments of the US neurovascular devices market?** A: Main segments include Interventional Neurology Devices, Neurovascular Stents, Embolic Agents, Catheters, and Flow Diverters. **Q: What is the market size for Interventional Neurology Devices in 2024?** A: The market size for Interventional Neurology Devices ranged from $400.0 Million to $800.0 Million. **Q: How does the market for Aneurysm Treatment compare to Ischemic Stroke treatment in 2024?** A: Aneurysm Treatment was valued between $300.0 Million and $600.0 Million, while Ischemic Stroke treatment ranged from $400.0 Million to $800.0 Million. **Q: What is the expected market size for hospitals in the US neurovascular devices market?** A: The market size for hospitals is projected to range from $600.0 Million to $1150.0 Million. **Q: What is the valuation range for Flow Diverters in 2024?** A: The valuation for Flow Diverters was between $217.31 Million and $310.44 Million. **Q: Which application segment is expected to have the highest market size in 2024?** A: The Ischemic Stroke application segment is expected to have the highest market size, ranging from $400.0 Million to $800.0 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-neurovascular-devices-market-14651*